DNA testing in primary care 'will transform treatment and cut costs'

Genotype-guided dosing of warfarin in primary care can improve patient outcomes and slash NHS spending on anticoagulants, according to a genetics expert.

Professor Sir John Burn (Photo: Pete Hill)
Professor Sir John Burn (Photo: Pete Hill)

Clinical geneticist Professor Sir John Burn told GPs at the 2014 RCGP annual conference in Liverpool that the breakthrough could transform prescribing in primary care, as point-of-care DNA testing becomes cheaper and more convenient.

Professor Burn, from Newcastle University, said it was now possible to test a patient’s genetic sensitivity to warfarin within 20 minutes for just £20, and the technology could soon be available in primary care.

The same machine will let the GP know the correct dose of warfarin for a patient.

Professor Burn said this would greatly improve outcomes. ‘It’s like saying, don’t buy shoes until you know what size your feet are. You wouldn’t just take away a size seven and hope it fits,’ he said.

‘There are two genes involved in warfarin metabolism. We know that there are three very common variants [of these genes] in our population. If you test for those three variants, you can accurately predict people’s [required] dosage.’

Recent NICE guidance for AF recommended wider use of novel oral anticoagulants (NOACs) as alternatives to warfarin, which requires regular monitoring and is difficult to dose correctly.,/p>

But there are fears this is driving up NHS spending, as these treatments are estimated to cost more than three times the price of warfarin.

‘We can't afford to put everyone on NOACs and we don’t need to,’ said Professor Burn. ‘What we’re trying to do is demonstrate that warfarin can continue to be used if you genotype people.’

Professor Burn and his team have started to roll a scheme to trial point-of-care testing and genotype-led dosage adjustment in Newcastle.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins


Already registered?

Sign in

Follow Us:

Just published

The original Moderna COVID-19 vaccine

First COVID-19 vaccine to target Omicron variant approved for use in UK

The MHRA has approved an updated version of the Moderna vaccine that targets both...

Ballot box

Majority of GPs back taking industrial action in the coming year, poll suggests

The majority of GPs support taking industrial action in the coming 12 months to push...

RCGP sign

NHS winter plan does not provide enough support for GPs, warns RCGP

NHS England's winter plan does not include enough measures to support general practice...

NHS sign

Plans to recruit 1,000 new link workers to support GP practices this winter

NHS England has set out plans to recruit an additional 1,000 social prescribing link...

BMA House

BMA prepares to ballot junior doctors on industrial action

Junior doctors will be balloted over industrial action if the government does not...

Typing on a laptop

NHS 111 systems could be offline until next week following cyber attack

NHS 111 systems could be offline until next week following the cyber attack on a...